Updated hourlyHourly refreshThu, Jul 23, 2026
Press Release Database
Recent press releases, indexed by topic.
Finance · AI
(PR-inside.com) Experienced Healthcare Information Technology Specialist Joins Leading Pharmaceutical IT Company TAMPA, FL / ACCESS Newswire / July 15, 2026 /Wellgistics Health, Inc. (the "Company" or "Wellgistics") (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today announced that it appointed healthcare information technology executive Brett Thompson as the Company's consulting Chief Technology Officer (CTO). Mr. Thompson has more than thirty years of experience designing, developing, and leading enterprise software solutions, including more than seventeen years focused on healthcare and pharmacy technology. Throughout his career, he has structured and delivered commercial softwar
Jul 15 · 11:40·PR-Inside
Healthcare
Experienced Healthcare Information Technology Specialist Joins Leading Pharmaceutical IT Company
Jul 15 · 11:40·Newswire.com
Finance · Healthcare
NEWTON, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (Acumen), a clinical-stage biopharmaceutical company developing novel therapeutics that target soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), today announced new findings presented at the Alzheimer's Association International Conference (AAIC ® ) 2026 in London. Following collaboration with JCR Pharmaceuticals Co., Ltd. (JCR) on EBD candidate development, studies demonstrated improved brain penetration of anti-AβO antibodies through transferrin receptor-mediated delivery across both mouse and non-human primate models. Additionally, research from early symptomatic AD patients highlighted the lived experience among ALTITUDE-AD trial participants and their study p
Jul 15 · 11:30·GlobeNewswire
Finance · Healthcare
PHILADELPHIA and VANCOUVER, British Columbia, July 15, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, announces a manufacturing arrangement with FUJIFILM Biotechnologies California, a leading contract development and manufacturing organization (CDMO) specializing in cell therapies, to support the ongoing pivotal Phase 3 clinical development and potential future commercial supply of BriaCell’s lead clinical candidate, Bria-IMT, an off-the-shelf allogenic cell therapy.
Jul 15 · 11:30·GlobeNewswire
Finance · Healthcare
Demonstrated Favorable Safety Profile and Preliminary Clinical Activity in Relapsed/Refractory Multiple Myeloma
Jul 15 · 11:30·GlobeNewswire
AI · SaaS
XRHealth acquires Swing Therapeutics to expand its AI-powered digital health platform beyond XR into mobile apps, wearables, and FDA-authorized digital therapeutics for chronic pain and fibromyalgia, creating a comprehensive, reimbursable care platform BOSTON, July 15, 2026...
Jul 15 · 11:00·PRWeb
Healthcare
A different kind of mental health benefit for self-insured employers: a dedicated, employed team of therapists, care that sees the whole person across mental and physical health, and the workforce intelligence to prove it. SEATTLE, July 15, 2026 /PRNewswire-PRWeb/ -- For thirty years, the...
Jul 15 · 10:49·PRWeb
Finance · Healthcare
(PR-inside.com) July session to spotlight the specialized, coordinated commercial organization that turns product innovation into clinical adoption, sustained utilization, and long-term recurring revenue ANN ARBOR, MI / ACCESS Newswire / July 15, 2026 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the next installment of its "Fourth Friday at Four" investor webinar series, scheduled for Friday, July 24 at 4:00 p.m. Eastern Time. The July program, titled " Fourth Friday at Four - Zomedica's Sales Organization: From Strategy to the Clinic ," will give current ..
Jul 15 · 10:00·PR-Inside
Finance · Healthcare
Up to 84% of GLP-1 induced weight loss retained with Revita® versus 46% with sham at one year in patients receiving complete duodenal ablations
Jul 15 · 10:00·GlobeNewswire
Healthcare
Lila Karoub has completed a new book, "I Was A Therapist": True Case Studies of Child Abuse, Attempted Murder, and Marital Torture, a candid examination of the most challenging and transformative moments from her decades as a practicing psychotherapist. Drawing from her clinical experience, Karoub recounts pivotal cases involving attempted homicide, severe childhood trauma, and intimate partner [PR.com]
Jul 15 · 10:00·PR.com
Healthcare
Doha, Qatar – , 2026-07-15 — /EPR Network/ — First Vet is happy to offer trusted Veterinary Lab Testing in Doha for pets. The clinic [read full press release...]
Jul 15 · 09:43·Express Press Release
Finance · Healthcare
Tokyo, Japan and Cambridge and London, UK, 15 July 2026 – Nxera Pharma Co. Ltd (“Nxera”; TSE 4565) will announce its earnings results and present operational highlights for 2Q 2026 on Friday, 7 August 2026. The Company will host a live webinar presentation with Chris Cargill (President, CEO), Hironoshin Nomura (CFO), Toshi Maeda (COO) and Patrik Foerch (CSO and President of Nxera Pharma UK), at 5:00 pm JST (9:00 am GMT) on Friday, 7 August 2026. The webinar is open to all existing and potential investors as well as sell-/buy-side analysts and will consist of a presentation followed by a Q&A session. Please click here to pre-register, which will provide a link to access the webinar. Presentation slides will be made available by 4:30 pm JST (8:30 am GMT) on 7 August 2026 through the inve
Jul 15 · 09:13·GlobeNewswire